Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-23-018783

Director sold 4,000 shares at $7.98 ($31,920)

  • Director acquired 16,745 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SANDERS MACHELLE · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-13 Grant or award : show line 1 in the form +16,745 29,611 D
2023-06-15 Sale : show line 2 in the form −4,000 $7.98 $31,920 25,611 D
Open-market sales · 4,000 sh · avg $7.98 · $31,920

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-13 Grant or award : show line 3 in the form Automatic Stock Option Grant +39,072 39,072 D
Loading xslF345X04/form4.xml…